Hydroxyurea therapy in E-β-thalassemia:: Effect on hemoglobin and on RBC characteristics.

被引：0
|
作者：
Singer, ST
Kuypers, F
Mignacca, R
Kennedy, N
Olivieri, N
Weatherall, D
Vichinsky, E
机构：
[1] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA
[2] Valley Childrens Hosp, Fresno, CA USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1878
引用
收藏
页码：424A / 424A
页数：1
相关论文
共 48 条
  • [31] Efficacy and safety of oral 3-hydro-4N-trimethyl amino butyrate as a stimulator for fetal globin synthesis in hemoglobin E-β thalassemia and β thalassemia.
    Adhikari, D
    BasuRay, T
    Das, MK
    Basu, AK
    Chandra, S
    BLOOD, 1999, 94 (10) : 28B - 29B
  • [32] Comparison of efficacy and safety of thalidomide vs hydroxyurea in patients with Hb E-β thalassemia-a pilot study from a tertiary care Centre of India
    Jain, Manisha
    Chakrabarti, Prantar
    Dolai, Tuphan Kanti
    Ghosh, Pramit
    Mandal, Prakas Kumar
    Baul, Shuvra Neel
    De, Rajib
    BLOOD CELLS MOLECULES AND DISEASES, 2021, 88
  • [33] An Observational Study of the Effect of Hemoglobinopathy, Alpha Thalassemia and Hemoglobin E on P. Vivax Parasitemia
    Para, Suparak
    Mungkalasut, Punchalee
    Chanda, Makamas
    Nuchprayoon, Issarang
    Krudsood, Srivicha
    Cheepsunthorn, Chalisa Louicharoen
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2018, 10
  • [34] IRON-ABSORPTION IN PATIENTS WITH BETA-THALASSEMIA HEMOGLOBIN-E DISEASE AND THE EFFECT OF SPLENECTOMY
    VATANAVICHARN, S
    ANUWATANAKULCHAI, M
    TUNTAWIROON, M
    SUWANIK, R
    WASI, P
    ACTA HAEMATOLOGICA, 1983, 69 (06) : 414 - 416
  • [35] Effect of combination therapy of hydroxyurea with l-carnitine and magnesium chloride on hematologic parameters and cardiac function of patients with β-thalassemia intermedia
    Karimi, Mehran
    Mohammadi, Faranak
    Behmanesh, Farzane
    Samani, Soleiman M.
    Borzouee, Mohammad
    Amoozgar, Hamid
    Haghpanah, Sezaneh
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 84 (01) : 52 - 58
  • [36] INHIBITORY EFFECT OF BETA-O-THALASSEMIA HEMOGLOBIN-E ERYTHROCYTES ON PLASMODIUM-FALCIPARUM GROWTH-INVITRO
    YUTHAVONG, Y
    BUTTHEP, P
    BUNYARATVEJ, A
    FUCHAROEN, S
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1987, 81 (06) : 903 - 906
  • [37] Effect of antiretroviral therapy on hemoglobin A2 values can have implications in antenatal beta-thalassemia screening programs
    Bhagat, Priyanka
    Sachdeva, Ravinder Kaur
    Sharma, Prashant
    Sachdeva, Man Updesh Singh
    Chhabra, Sanjeev
    Sharma, Aman
    Das, Reena
    INFECTIOUS DISEASES, 2016, 48 (02) : 122 - 126
  • [38] The effect of single and combination drug therapy on previously transfused E/β-thalassemia patients:: Implications on decision-making for therapy.
    Singer, ST
    Kuypers, FA
    Coates, TD
    Robert, M
    Olivieri, NF
    Weatherall, DJ
    Vichinsky, EP
    BLOOD, 2002, 100 (11) : 119A - 120A
  • [39] Iron chelation therapy with deferiprone improves oxidative status and red blood cell quality and reduces redox-active iron in β-thalassemia/hemoglobin E patients
    Morales, Noppawan Phumala
    Rodrat, Supot
    Piromkraipak, Pannaree
    Yamanont, Paveena
    Paiboonsukwong, Kittiphong
    Fucharoen, Suthat
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 145
  • [40] EFFECT OF SUBCUTANEOUS IRON-CHELATOR THERAPY ON THE AMOUNT OF VITAMIN-E IN BETA-THALASSEMIA MAJOR PATIENTS
    TUCHSCHMID, P
    RIESER, F
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1983, 113 (40) : 1482 - 1483
12345